Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOPE-70 RCT: Low- and Moderate-Intensity Statin for Primary Prevention in Adults Over 70
KCT0004711Phase 4Recruiting
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of ulinastatin in cardiac morbidity, hypercholesterolemia, sponsored by Samjin Pharmaceutical Co., Ltd.. Started Apr 2020; status: recruiting.
02
Drugs
ulinastatin
03
Conditions
cardiac morbidityhypercholesterolemia
Beyond the preview
Go deeper on KCT0004711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004711.